Eileen Brewer

The Nanodropper is a universal adapter that attaches to existing eyedrop bottles to reduce the size of the droplet. By reducing wasted medication, it will minimize side-effects, lower the price per dose, improve access to expensive medications like those for glaucoma, and ultimately improve patient adherence and outcomes.

OtoNexus Medical Technologies is revolutionizing the diagnosis and management of middle ear infections. The OtoNexus technology platform harnesses the power of ultrasound technology to rapidly and accurately determine both the presence and the type of fluid behind the eardrum, providing a superior alternative to outdated diagnostic methods. By accurately determining the type of infection, healthcare providers can avoid prescribing antibiotics when they are not needed, helping to combat the growing issues of antibiotic resistance. Accurate diagnoses and appropriate treatment could reduce healthcare costs by minimizing complications and the need for additional treatments or follow-up visits. Patients will benefit from a faster, non-invasive diagnostic procedure, leading to quicker treatment and potentially shorter recovery times. Healthcare providers will benefit from a reliable and easy-to-use tool that enhances their diagnostic capabilities and supports their decision-making process. One-use-per-patient proprietary disposable tips incorporating this new patented ultrasound technology create a recurring revenue stream. The device is a simple, affordable, portable, lightweight, non-invasive tool that provides data in 1-2 seconds on the type of middle ear infection. With this information, healthcare providers can accurately assess middle ear infections and responsibly treat them with antibiotics when appropriate.

WAKE’s mission is amplify the work of women leading change globally. WAKE engages technologists and experts from innovative companies to maximize results for global women’s organizations. WAKE links high-impact, innovative women’s organizations to technology tools and expertise from leading companies to help organizations accelerate their impact and scale their work. We work closely with our private sector partners to provide tools, products, advisers and resources. Women’s organizations are leading the charge to address the most critical issues impacting women and girls, including gender-based violence, trafficking, child marriage, access to healthcare and education, political participation, and economic empowerment.

AudPop is a groundbreaking social impact media platform and the single largest grassroots movement of the most diverse, largest professional and amateur filmmakers. With its innovative approach and powerful capabilities, AudPop is poised to revolutionize the way we engage with content creation, audience participation, and community building. AudPop has a diversified business model that includes video and content submissions software, events, video library, subscriptions, and original content. We help companies: * Unleash the Power of User-Generated Content through turnkey video submissions software * Amplify Audience Engagement and Participation through contests, social media, and events * Discover New Talent and Diverse Voices through our vast community of content creators * Streamline Content Curation and Licensing * Enhance Data-driven Insights and Monetization AudPop provides: * 250K registered members * 75K registered global filmmakers/video creators * $10M awarded to content creators * 3500 hours of films + video on platform * Proprietary video submissions software * FAST channel forthcoming AudPop’s global footprint includes offices in New York City, Los Angeles, Montana, and New Delhi.

It all starts with a map. An industry game-changer, RippleNami is the first easy-to-use, intuitive visualization platform that allows anyone to map their world. RippleNami believes that, empowered with real-time information, people around the globe can connect and create positive change. By integrating millions of data points from numerous sources, RippleNami offers a complete picture of timely, relevant information, to connect people and organizations to what really matters to them. RippleNami fosters collaboration and delivers actionable insights to users across enterprises, universities, NGOs and emergency management services, enabling them to make better and faster critical decisions. RippleNami frees users from information silos, making big data relevant, decipherable and actionable. The cloud-based, device-agnostic and cost-effective platform can be customized to control access to valuable data with specific profiles and permission levels. The only mapping solution of its kind, RippleNami helps deliver real-time information on any device, allowing users the power to easily solve problems, make critical decisions and collaborate like never before.

Golden Seeds is an investment firm dedicated to pursuing market returns through the empowerment of women entrepreneurs and the people who invest in them. The group was founded in 2005 and is headquartered in New York City, with active chapters in Arizona, Atlanta, Boston, Dallas, Houston, New Jersey, and Silicon Valley – and active members throughout the country. Golden Seeds’ Angel Network has grown to become one of the largest in the country with around 280 members nationwide. Since 2005, over 3200 companies have applied to Golden Seeds for funding. All companies are evaluated, many proceed through due diligence and receive extensive guidance from Golden Seeds investors. In total, Golden Seeds has invested over $170 million in nearly 235 companies through its angel network and its venture funds. Moreover, the firm and its investors have provided important leadership in this investment sector. www.goldenseeds.com

The Virtuix Omni™ motion platform enables players to explore endless VR worlds, moving freely and at full speed in 360° without hitting any walls. Walk, run, and turn in 360° in virtual reality games and other applications!

Designed for use as a placeholder in your Experience section to summarize skills, competencies, and expertise developed across multiple companies.

757 Accelerate is a selective, mentor-driven startup acceleration program that connects promising startup founders with vetted mentors, investors, resources, and a lean startup education to help startups do more faster.

757 Collab is collaborative vehicle focused on growing an interconnected, inclusive, and impactful entrepreneurial ecosystem. 757 Collab manages and coordinates the activities of 3 resource groups: 757 Angels, 757 Accelerate and 757 Startup Studios. 1.) 757 Startup Studios (space/programs/incubator): 757 Startup Studios is located within Assembly, an iconic campus for makers and creators in the heart of Downtown Norfolk. The Studios is a selective program that offers early stage high growth, high tech startups rent free tenancy while surrounding this with as many resources as possible to focus on growing their startup as fast as possible. 2.) 757 Accelerate (Accelerator/Programs): A selective 12 week, mentor-driven startup acceleration program that connects promising startup founders with vetted mentors, investors, resources, and a lean startup education to help startups do more faster. 3.) 757 Angels (Capital/Angel Network): Where the investing happens! Connecting Start-up and Early Stage Companies to Capital & providing leadership to help build a stronger Entrepreneurial Ecosystem.

The Nanodropper is a universal adapter that attaches to existing eyedrop bottles to reduce the size of the droplet. By reducing wasted medication, it will minimize side-effects, lower the price per dose, improve access to expensive medications like those for glaucoma, and ultimately improve patient adherence and outcomes.

OtoNexus Medical Technologies is revolutionizing the diagnosis and management of middle ear infections. The OtoNexus technology platform harnesses the power of ultrasound technology to rapidly and accurately determine both the presence and the type of fluid behind the eardrum, providing a superior alternative to outdated diagnostic methods. By accurately determining the type of infection, healthcare providers can avoid prescribing antibiotics when they are not needed, helping to combat the growing issues of antibiotic resistance. Accurate diagnoses and appropriate treatment could reduce healthcare costs by minimizing complications and the need for additional treatments or follow-up visits. Patients will benefit from a faster, non-invasive diagnostic procedure, leading to quicker treatment and potentially shorter recovery times. Healthcare providers will benefit from a reliable and easy-to-use tool that enhances their diagnostic capabilities and supports their decision-making process. One-use-per-patient proprietary disposable tips incorporating this new patented ultrasound technology create a recurring revenue stream. The device is a simple, affordable, portable, lightweight, non-invasive tool that provides data in 1-2 seconds on the type of middle ear infection. With this information, healthcare providers can accurately assess middle ear infections and responsibly treat them with antibiotics when appropriate.